|
|
|
Volumn , Issue 46, 2003, Pages 1-4
|
|
Atomoxetine for attention deficit/hyperactivity disorder.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
PLACEBO;
PROPYLAMINE;
ADOLESCENT;
ADULT;
ARTICLE;
ATTENTION DEFICIT DISORDER;
CANADA;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST;
DRUG APPROVAL;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PSYCHOLOGICAL RATING SCALE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
UNITED STATES;
ADOLESCENT;
ADULT;
ANTIDEPRESSIVE AGENTS;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CANADA;
CHILD;
COSTS AND COST ANALYSIS;
DRUG APPROVAL;
HUMANS;
PLACEBO EFFECT;
PROPYLAMINES;
PSYCHIATRIC STATUS RATING SCALES;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0037607756
PISSN: 14886324
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
